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Abstract
Background: Anaphylaxis is a serious allergic disease that may lead to death if not immediately recognized and
treated. Triggers of anaphylaxis including food, drugs, and insect stings can vary widely. The incidence of anaphylaxis
seems to be affected by age, sex, atopy, and geographic location. This study aims to examine the common triggers of
anaphylaxis in Qatar.
Methods: A total of 1068 electronic medical records were audited using power chart system: 446 from the medical
coding system of anaphylaxis and 622 from the epinephrine auto-injectors (EAIs) dispensed during January 2012–
December 2017.
Results: Of 1068 patients, 574 (53.5%) had anaphylaxis; male to female ratio was 1.2, and 300 patients (77.9%) were less
than 10 years old. The common triggers were food (n= 316, 55.0%), insect stings (n = 161, 28.0%), and drugs (n = 103,
17.9%). Common anaphylaxis food triggers were nuts (n = 173, 30.1%), eggs (n = 89, 15.5%), and seafood (n = 72,
12.5%), and common anaphylaxis medication triggers were antibiotics (n = 49, 8.5%) and nonsteroidal anti-inflammatory
drugs (n = 30, 5.2%). Interestingly, 135 anaphylactic patients (23.5%) were due to black ant stings. The
anaphylaxis triggers varied significantly between children and adults. Among children (less than 10 years),
three quarters of the events were triggered by food (223, 74.3%) while among adults (20–55 years), insect
stings (n = 59, 43.0%) and drugs (n = 44, 32.0%) were dominant.
Discussion: This is the first national study stratifying anaphylaxis triggers among different age groups in
Qatar. This study will serve as a guide for clinical practice in allergy clinics in Qatar and will help to assess
future trends of anaphylaxis in Qatar.
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Background
Anaphylaxis is a serious systemic allergic reaction that is
rapid in onset and may be fatal if not immediately recog-
nized and treated [1–3]. Triggers of anaphylaxis vary widely
and include food, drugs, and insect stings. Once triggered,
the disease manifests itself by compromising the function
of multiple organs, including skin (90%), respiratory (70%),
gastrointestinal (30–45%), cardiovascular (35%) and central
nervous system (10–15%) [2, 4]. Personal predisposition
and family history of atopy usually worsen the course of
anaphylaxis in affected subjects [2–4].
Although it is difficult to characterize anaphylaxis
incidence due to its transient acute nature and
under-recognition especially in case of cutaneous symp-
toms absence (20% of the cases) [3, 5, 6]. Several studies
from USA, UK, and Australia suggested that the inci-
dence of anaphylaxis is on a gradual rise over the last
two decades [7–14]. To estimate the incidence, preva-
lence, and triggers, scientists have used different meth-
odologies including patients’ case reports [15–17],
international medical coding systems [7–9, 18–24], hos-
pital admission rates [11, 13, 25, 26], public surveys and
epinephrine dispense records [10, 12, 21, 25, 27, 28].
These studies have demonstrated that distribution of
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geographical residence, and socioeconomic status of
involved subjects.
Anaphylaxis was described in a few case-reports in
Qatar [15, 29–31], however, its triggers have not been
thoroughly studied. The aim of this study is to retrospect-
ively estimate and describe the distribution of anaphylaxis
triggers in different age and gender groups in Qatar from
January 2012 to December 2016.
Method
Data collection
Between January 2012–December 2016, electronic medical
records were reviewed retrospectively using Cerner power
chart system. This includes patients admitted and regis-
tered in Cerner power chart system with the International
Classification of Diseases 10th revision-Australian Modifi-
cation (ICD10-AM) and discharged with diagnostic codes
of anaphylaxis: T 78.0 (anaphylactic shock due to adverse
food reactions), T 78.1 (other adverse food reactions, not
elsewhere classified), T78.2 (anaphylactic shock, unspeci-
fied), T80.5 (anaphylactic shock due to serum), or T88.6
(anaphylactic shock due to adverse effect of correct drug
or medication properly administered) and patients who
had Epinephrine Auto-Injector (EAIs) dispensed from
Hamad General Hospital pharmacy (Fig. 1).
Sample selection
The study was approved by Hamad Medical Corporation
(HMC) local ethics committee (IRB 17122/17). Anaphyl-
axis was defined based on physician diagnosis and the
clinical protocols of HMC that are in accordance with
the clinical criteria of anaphylaxis guidelines [32]. Our
inclusion criteria patients with anaphylaxis were either
one of the following: (1) acute onset of illness (minutes
to several hours) with involvement of the skin, mucosal
tissue or both, and at least respiratory compromise or
reduced blood pressure; (2) involvement of two or more:
skin-mucosal, respiratory, gastrointestinal and/ or
hypotension (minutes to several hours) after exposure to a
likely allergen; or (3) reduced blood pressure after exposure
to a known allergen (minutes to several hours). Generalized
Allergic Reaction (GAR) was identified as patients who
were exposed to triggers that resulted in symptoms of aller-
gic reaction without fulfilling the clinical criteria of anaphyl-
axis. Patients with GAR may have underlying allergic
diseases such as asthma, atopic dermatitis, urticaria, angio-
edema or allergic rhinitis. Anaphylaxis and GAR definitions
were applied to the records that were reviewed. Demo-
graphic information and clinical diagnosis of patients were
retrieved, reviewed, and documented anonymously, and
then sub-categorized to be analyzed based on gender, age,
history of atopy, symptoms, and triggers.
Triggers
Triggers were defined as etiological agents that may lead
to either GAR or anaphylaxis [1, 3] . Triggers were clas-
sified into food, drugs, insect stings, or idiopathic fac-
tors. All the triggers of allergic reactions and anaphylaxis
were identified based on patient’s history of exposure to
the triggers and the circumstances accompanying the
reactions that have been recognized and confirmed by
the treating physician. These details were documented
by the treating physicians in the electronic medical
records. When possible triggers of the reactions were
not clearly recognized by the patients or physicians, they
were classified to be idiopathic.
Statistical analysis
Data analysis was performed using Statistical Package for
Social Sciences (SPSS Chicago IL, USA). Groups were
compared using chi-square test and the Fisher’s exact test
(two-tailed) replaced the chi-square in case of small
sample size, where the expected frequency is less than 5 in
any of the cells. The level where P < 0.05 (two-tailed) was
considered as the cut-off for significance.
Fig. 1 Flowchart of the study design
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Results
Characteristics of the study population
Out of 1068 electronic medical records audited using
Cerner power chart system; 446 inpatients registered
with ICD-10 codes of anaphylaxis and 622 outpatients
had EAIs dispensed. Five hundred seventy-four patients
(53.5%) had anaphylaxis; 315 (54.8%) were males and
300 (52.2%) were children less than 10 years old, 251
patients (43.7%) were Qatari, 162 patients (28.2%) were
non-Qatari Arabs, and 118 patients (20.5%) were Asian.
Personal history of asthma, atopic dermatitis, urticaria
and allergic rhinitis were determined in 208 (36.2%), 195
(33.9%), 179 (31.1%), and 81 (14.1%) respectively.
One-fifth of the study population had a positive family
history of atopy (Table 1).
Triggers
Overall, triggers were not identified in 44 cases (7.6%) of
anaphylaxis and five cases (3.7%) of GAR. Food accounted
for 403 (37.7%), followed by insects’ stings 184 (17.2%) and
drugs 123 (11.5%). The common triggers of anaphylaxis
are detailed in Table 2. Other triggers that contributed to
anaphylaxis were cold (3, 0.5%), latex (2, 0.3%), contrast
media (2, 0.3%), exercises (1, 0.1%) and food-dependent
exercise-induced anaphylaxis (1, 0.1%) (Table 2).
Age and gender variation in anaphylaxis
Insects’ stings, food, and drug were significantly different
between the different age groups (P < 0.001), while only
the food and insects’ stings showed significance among gen-
der groups (P < 0.001). The nationality of patients with
anaphylaxis showed no such significant difference in rela-
tion to anaphylaxis triggers (Additional file 1: Table S1).
The distribution of anaphylaxis and GAR among different
age and gender groups is shown in Fig. 2.
Discussion
This study stratifies anaphylaxis triggers among different
age and gender groups and provides a profile of the
common allergens that trigger anaphylaxis, to alert clini-
cians and serve as a baseline to assess future trends of
anaphylaxis triggers in Qatar. We were able to identify
Table 1 Characteristics of the study population
Characteristic Total N = 1068 n (%) Anaphylaxis N = 574 n (%) GAR N = 132 n (%) P-value
Age (Years)
< 10 603 (56.3) 300 (52.2) 85 (64.3) 0.009a
10–19 210 (19.7) 109 (18.9) 22 (16.6)
20–55 209 (19.6) 137 (23.8) 21 (15.9)
>. 55 46 (4.3) 28 (4.8) 4 (3.0)
Gender
Male 612 (57.3) 315 (54.8) 83 (62.8) 0.095
Female 456 (42.7) 259 (45.2) 49 (37.1)
Nationality, N = 1067b
Qatari 438 (41.0) 251 (43.7) 63 (47.7) 0.009
Non-Qatari, Arab 303 (28.4) 162 (28.2) 25 (18.9)
Asian 228 (21.4) 118 (20.5) 24 (18.1)
Others 98 (9.2) 42 (7.3) 20 (15.1)
Personal History
Asthma 357 (36.4) 208 (36.2) 68 (51.5) < 0.001
Atopic dermatitis 326 (33.2) 195 (33.9) 66 (50) < 0.001
Urticaria/ angioedema 254 (25.9) 179 (31.1) 36 (27.2) 0.485
Allergic rhinitis 142 (14.5) 81 (14.1) 30 (22.7) 0.009
Family History, N = 123
Atopy c 70 (56.9) 58 (10.1) 8 (6.1) 0.989
Anaphylaxis 6 (4.9) 5 (0.8) 1 (0.7)
Consanguinity, N = 33 30 (90.9) 25 (4.3) 2 (1.5) 1.000*
GAR generalized allergic reactions
a Chi-square for trend (linear by linear association)
b One patient had no listed nationality in the system
c Atopy includes asthma, atopic dermatitis, urticaria and allergic rhinitis
*P-value is for Fischer test (exact significant 2-sided)
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574 cases of anaphylaxis out of 1068 records. Food was
the leading trigger of anaphylaxis in children regardless
of gender. Anaphylaxis induced by drugs and insects’
stings was more common among female adults (Fig. 2).
Interestingly, 23.5% of patients had anaphylaxis by black
ants.
Our data showed a predominance of anaphylaxis
among pediatrics (n = 300, 52.2%), which is reasonable
since at a single time point anaphylaxis is initially diag-
nosed at childhood, and relevant triggers avoidance is
recommended as preventive measures of a long-term
action plan and risk reduction. However, such avoidance
measures are neither easily nor strictly followed by
children of this age group [16, 17, 33].
Anaphylaxis was common in two age/gender groups:
male children (n = 224, 39.0%) and female adults (n = 114,
19.8%) (Fig. 2), which is consistent with other findings re-
ported by Alshami et al. where they found an incidence of
anaphylaxis in pediatric emergency centers of 13.3 per
100,000 visits with 69% of patients being males [34], and
Mehdi et al. showed that the incidence among adults was
16.5 per 100,000 visits with 78% being females [35].
Table 2 Causative triggers of symptoms in the study population
Causative triggers Total N = 1068 n (%) Anaphylaxis N = 574 n (%) GAR N = 132 n (%) P-value
Food (All) 403 (37.7) 316 (55.0) 87 (65.9) < 0.001
Nuts a 232 (21.7) 173 (30.1) 59 (44.6) < 0.001
Egg 113 (10.5) 89 (15.5) 24 (18.1) 0.171
Seafood 93 (8.7) 72 (12.5) 21 (15.9) 0.111
Peanuts 92 (8.6) 71 (12.3) 21 (15.9) 0.100
Cow’s milk 77 (7.2) 61 (10.6) 16 (12.1) 0.326
Sesame seeds 65 (6.1) 50 (8.7) 15 (11.3) 0.158
Wheat 38 (3.5) 35 (6.1) 3 (2.2) 0.130
Other food b 150 (14.0) 126 (21.9) 24 (18.1) 0.933
Insects’ stings (All) 184 (17.2) 161 (28.0) 23 (17.4) 0.122
Black ant 153 (14.3) 135 (23.5) 18 (13.6) 0.101
Bee 3 (0.2) 3 (0.5) 0 (0.0) 1.000*
Wasp 1 (0.1) 1 (0.1) 0 (0.0) 1.000*
Unspecified 29 (2.7) 24 (4.1) 5 (3.7) 0.798*
Drugs (All) 123 (11.5) 103 (17.9) 20 (16.2) 0.978
Antibiotics 58 (5.4) 49 (8.5) 9 (6.8) 0.883
Augmentin 19 (1.7) 16 (2.7) 3 (2.2) 1.000*
Penicillin 14 (1.3) 11 (1.9) 3 (2.2) 0.484*
Ceftriaxone 6 (0.5) 6 (1.0) 0 (0.0) 0.596*
Amoxicillin 6 (0.5) 5 (0.8) 1 (0.7) 1.000*
Other antibiotics 22 (2.0) 19 (3.3) 3 (2.2) 1.000*
NSAID c 36 (3.3) 30 (5.2) 6 (4.5) 0.938
Ibuprofen 28 (2.6) 23 (4.0) 5 (3.7) 0.794*
Paracetamol 8 (0.7) 8 (1.3) 0 (0.0) 0.366*
Diclofenac 8 (0.7) 7 (1.2) 1 (0.7) 1.000*
Aspirin 3 (0.3) 3 (0.5) 0 (0.0) 1.000*
Other NSAID 4 (0.3) 4 (0.6) 0 (0.0) 1.000*
IvIg d 4 (0.3) 4 (0.6) 0 (0.0) 1.000*
Vaccines 3 (0.3) 3 (0.5) 0 (0.0) 1.000*
Other drugs 41 (3.8) 35 (6.1) 6 (4.5) 0.779
Idiopathic (All) 49 (4.5) 44 (7.6) 5 (3.7) 0.245
aNuts included cashew, pistachio, tree nuts, coconuts and hazelnuts excluding peanuts which has been counted separately
bOther food included chickpeas, bean, lentil, strawberry, banana, kiwi, mango, chicken, beef, pineapple, apple, and watermelon
cNSAID non-steroidal anti-inflammatory drugs
dIvIg Intravenous immunoglobulin
*P-value is for Fischer test (exact significant 2-sided)
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Several studies in different ethnic groups showed similar
age and gender distribution of anaphylaxis among differ-
ent age/gender groups; for example, an epidemiological
study based on measuring the anaphylaxis rates in emer-
gency department visits in hospitals across Florida, USA,
reported that the highest anaphylaxis incidence rate was
among the youngest males (8.2/100,000 visits) and the
adult females (10.9/100,000 visits) [20]. Similar to this,
findings from the Rochester epidemiology project from
1990 through 2000 showed that age-specific incidence rate
of anaphylaxis was the highest for ages 0–19 years [8].
In our patients’ cohort, we observed that the association
between the development of anaphylaxis compared to GAR
and the national origin were statistically significant (p-value
= 0.009) (Table 1). For instance, “Non-Qatari Arabs” had
relatively higher prevalence of anaphylaxis compared to
GAR while “Others” such as European, American and
African had relatively lower prevalence of anaphylaxis com-
pared to GAR. Such differences in the rates of anaphylaxis
compared to GAR associated with ethnic and national
groups can be explained by a number of factors, including
genetic and environmental exposure. Qatar is a melting pot
Fig. 2 Distribution of anaphylaxis pattern among different age and gender groups. a Food triggers, b Insect stings triggers, c Drug triggers,
d Idiopathic triggers
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of hundreds of nationalities of migrant workers [36] that
may have different genetic predisposition to allergy and
anaphylaxis. In addition to potential differences in the gen-
etic make-up, different life style and dietary patterns as well
as differential prevalence of illnesses and use of varying
medications may be some of the factors that may or may
not contribute to such differences [18, 23]. In general, ana-
phylaxis was common [7–9, 20, 21], more associated with
repeated use of epinephrine [27] and more fatal [23] among
Caucasians compared to Black, Latino/Hispanic and Asian
ethnicities. In contrast, Mahdavinia et al. (2017) reported
that Caucasians had a lower rate of food allergy associated
anaphylaxis than African American and Hispanic children
[37]. Additionally, Buka et al. (2015) reported that
Caucasians had less incidence, and were less likely to
present with severe anaphylactic symptoms than South
Asian British children living in Birmingham [38].
Personal history of atopy for asthma (n = 208, p < 0.001),
atopic dermatitis (n = 195, p < 0.001) and allergic rhinitis
(n = 81, p = 0.009) were noted among patients with ana-
phylaxis in Qatar (Table 1), and 56.9% cases had positive
family history (Table 1). Although other studies showed no
such significant association between atopy and anaphylaxis
[39, 40], atopy was frequently visualized as a risk factor that
might worsen the clinical outcome of anaphylaxis [8, 18,
19, 21, 24, 41–43]. However, several studies stated that
anaphylaxis was common among patients with atopic dis-
eases. In comparison to our study, different distribution of
atopic diseases was observed [8, 18, 19, 21, 24, 41–43].
Our results showed that regardless of gender, food was
the culprit for anaphylaxis in children less than 10 years
(Fig. 2a). The major causative triggers of food-induced
anaphylaxis in Qatar were nuts and eggs, a finding that
was consistent with a Saudi finding reported in 2015
[14]. Peanuts, a major trigger of food-related anaphylaxis
in the United States [7, 9, 22], is ranked in the fourth
position after seafood in Qatar. In a prospective cohort
study conducted in Qatar from 2007 to 2010, anaphyl-
axis induced by cow’s milk proteins (CMP) was found in
10 children out of 38 allergic subjects and suggested
camel milk as a safer alternative choice after being experi-
mentally tested [30, 31]. With a larger study population,
anaphylaxis induced by cow’s milk was accounted for 61
(10.6%) from 2012 to 2016. In comparison, the prevalence
of CMP anaphylaxis resulted in 6–9% of children hospital
and emergency admission in the USA [7, 19, 21] and 10%
in the UK [44]. CMP anaphylaxis accounted for 8 fatalities
in UK children during the period from 1992 to 2012 [13].
Our data showed that sesame seed accounted for 8.7% of
anaphylaxis cases in Qatar (Table 2). However, as a global
allergen, sesame seed is affecting approximately 0.1% of
North American population and is the third common food
allergen in Israel [45]. In Lebanon, a cross-sectional study
showed that allergic reactions triggered by sesame seed
were of severe grade and manifested mainly in the form of
anaphylaxis [46]. This study suggested that the sesame seed
is the “Middle Eastern” peanut [46].
Anaphylaxis and GAR attributable to Hymenoptera
stings in our study demonstrated predominance in fe-
male adults (n = 50, 45.9%) and male children (n = 30,
40.0%) (Fig. 1b). Interestingly, 135 anaphylactic patients
(23.5%) developed anaphylaxis by the sting of black ant
which is a widespread ant in tropical Africa and the
Middle East and is a native insect in Arabian Desert
countries, including Qatar [47, 48]. Allergic reactions
due to black ant stings range from pain with local
itching at the sting site to severe anaphylactic shock.
AlAnazi et al. (2009) showed that the diversity of mani-
festation and human response to black ant stings in four
cases encountered in Al Riyadh, the capital city of Saudi
Arabia, and three patients were adult females [49]. In
contrast to our findings, lower prevalence of black ant
induced anaphylaxis was reported in Saudi Arabia (3.2%)
[14], and Singapore (12.9%) [50]. The unreported inci-
dence of black Samsum ant induced anaphylaxis was
recognized in Iran where most stings result in mild aller-
gic reactions [51]. However, in United Arab Emirates,
4 deaths were recorded after the sting of this ant [52].
Several studies attribute diversity of symptoms to the anti-
genicity variation of black ants’ toxin composition accord-
ing to geographical regions [51, 53]. Anaphylaxis in
Najran, a city in southwestern Saudi Arabia, was triggered
by a different species of black ant, Solenopsis richteri, in
non-Saudi expatriates (1997–1999) [54]. A Turkish retro-
spective review defined prevalence of Hymenoptera stings
anaphylaxis among adult patients, however, the causative
triggers were mainly honey bees and different wasp
species [55]. In contrary to Qatar, the later Turkish study
showed a predominance of Hymenoptera induced ana-
phylaxis among male adults (57.1%) [55]. In light of the
absence of studies published about black Samsum ant
abundance, distribution, and its toxin antigenicity in
Qatar, our results flag it as a public health hazard in Qatar
owing to its strong association with anaphylaxis.
A key strength of this work includes the fact that
Hamad General Hospital, a member of Hamad Medical
Corporation, is the only medical facility that dispenses
EAIs in Qatar. Therefore, using dispensed (EAI) records
of outpatients in combination with medical coding system
(ICD-10 AM) of anaphylaxis for inpatients would be an
accurate estimation of the prevalence of anaphylaxis in
Qatar. Although, EAI dispense records were available for
1 year only (January – December 2016), EAIs as a refilled
drug included dispense records of previous years.
Conclusion
Our study provides new data regarding the frequency of
anaphylaxis in our geographical region; however, it is
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prone to reporting bias due to its retrospective nature
and reliance on physician documentation. Besides that,
we had 364 medical records (34.1%) with missing data
or incomplete charts and we cannot assume them as be-
ing negative since there is the possibility of underreport-
ing by physicians. Therefore, the presenting data should
be interpreted with caution stating that “within the
boundary of available data” registered in Cerner
power chart system and out of 1068 subjects, 574
(53.5%) patients had a definite diagnosis of anaphylaxis
(2012–2016). Further studies are needed to confirm the
medical diagnosis of the missing cases using another
method. This study will serve as a platform for clinicians
in the allergy clinics in Qatar to improve patient care
and for further epidemiological studies for understand-
ing more about the prevalence of anaphylaxis in Qatar.
Our data might provide the baseline for assessing future
trends. We would recommend integrating entomology,
bioecology and medicine points of view to study black
ant anaphylaxis in Qatar.
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